Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$81.24 - $97.37 $3,818 - $4,576
47 Added 29.01%
209 $17,000
Q1 2024

May 10, 2024

SELL
$71.24 - $85.35 $51,862 - $62,134
-728 Reduced 81.8%
162 $13,000
Q4 2023

Feb 12, 2024

SELL
$80.59 - $92.61 $5,883 - $6,760
-73 Reduced 7.58%
890 $76,000
Q3 2023

Nov 13, 2023

SELL
$82.56 - $93.49 $27,575 - $31,225
-334 Reduced 25.75%
963 $86,000
Q2 2023

Aug 21, 2023

SELL
$80.84 - $89.45 $768,626 - $850,490
-9,508 Reduced 88.0%
1,297 $110,000
Q2 2023

Aug 10, 2023

BUY
$80.84 - $89.45 $772,830 - $855,142
9,560 Added 767.87%
10,805 $919,000
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $4,874 - $6,070
67 Added 5.69%
1,245 $103,000
Q4 2022

Feb 10, 2023

BUY
$73.85 - $86.14 $3,544 - $4,134
48 Added 4.25%
1,178 $92,000
Q3 2022

Nov 14, 2022

SELL
$63.3 - $78.66 $4,367 - $5,427
-69 Reduced 5.75%
1,130 $83,000
Q2 2022

Aug 10, 2022

BUY
$49.27 - $66.08 $6,355 - $8,524
129 Added 12.06%
1,199 $78,000
Q1 2022

May 04, 2022

SELL
$43.77 - $63.22 $19,171 - $27,690
-438 Reduced 29.05%
1,070 $58,000
Q3 2021

Nov 05, 2021

BUY
$57.6 - $70.59 $5,644 - $6,917
98 Added 6.95%
1,508 $107,000
Q2 2021

Aug 02, 2021

SELL
$51.81 - $118.56 $414 - $948
-8 Reduced 0.56%
1,410 $94,000
Q1 2021

May 13, 2021

SELL
$111.01 - $139.48 $51,619 - $64,858
-465 Reduced 24.69%
1,418 $158,000
Q4 2020

Feb 10, 2021

SELL
$88.75 - $119.95 $11,005 - $14,873
-124 Reduced 6.18%
1,883 $225,000
Q3 2020

Nov 12, 2020

BUY
$75.65 - $93.58 $2,647 - $3,275
35 Added 1.77%
2,007 $180,000
Q2 2020

Aug 14, 2020

BUY
$84.96 - $118.91 $11,979 - $16,766
141 Added 7.7%
1,972 $178,000
Q1 2020

May 18, 2020

BUY
$74.34 - $121.82 $136,116 - $223,052
1,831 New
1,831 $185,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.